Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(22):1688-1696; doi:10.1093/jnci/94.22.1688
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplemental Information
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Moore, L. E.
Right arrow Articles by Waldman, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, L. E.
Right arrow Articles by Waldman, F. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 22, 1688-1696, November 20, 2002
© 2002 Oxford University Press

ARTICLE

Arsenic-Related Chromosomal Alterations in Bladder Cancer

Lee E. Moore, Allan H. Smith, Clarence Eng, David Kalman, Sandy DeVries, Vivek Bhargava, Karen Chew, Dan Moore II, Catterina Ferreccio, Omar A. Rey, Frederic M. Waldman

Affiliations of authors: L. E. Moore, A. H. Smith, University of California at Berkeley School of Public Health, Berkeley; C. Eng, S. DeVries, V. Bhargava, K. Chew, D. Moore II, F. M. Waldman, University of California San Francisco Cancer Center, San Francisco; D. Kalman, University of Washington, Seattle; C. Ferreccio, Pontificia Universidad Católica de Chile, Santiago; O. A. Rey, Villa Maria, Cordoba, Argentina.

Correspondence to: Lee E. Moore, Ph.D., M.P.H., Occupational Epidemiology Branch, NCI, 6120 Executive Blvd., EPS 8118, MSC 7240, Bethesda, MD 20892-7240 (e-mail: moorele{at}mail.nih.gov).

Background: Previous studies have demonstrated that ingestion of arsenic in drinking water is a strong risk factor for several forms of cancer, including bladder cancer. It is not known whether arsenic-related cancers are genetically similar to cancers in unexposed individuals or what mechanisms of carcinogenesis may underlie their formation. This study was designed to compare chromosomal alterations in bladder cancers of arsenic-exposed individuals to provide insight into the mechanism of how arsenic may induce or promote cancer. Methods: A case–case study was conducted in Argentina and Chile examining chromosomal alterations in bladder tumor DNA in 123 patients who had been exposed to arsenic in their drinking water. Patients were placed into one of four arsenic exposure categories according to their average 5-year peak arsenic exposure. Patients were also classified as ever smokers or never smokers. Comparative genomic hybridization was used to identify chromosomal alterations throughout the genome. All statistical tests were two-sided. Results: The total number of chromosomal alterations was higher in individuals exposed to higher arsenic levels (5.7 ± 5.1, 5.6 ± 5.1, 7.3 ± 7.4, and 9.1 ± 6.5 [mean ± standard deviation] chromosomal alterations per tumor with increasing arsenic exposure; Ptrend = .02, adjusted for stage and grade). The trend was stronger in high-grade (G2–G3) tumors (6.3 ± 5.5, 8.3 ± 4.7, 10.3 ± 7.8, and 10.5 ± 6.4 alterations per tumor; Ptrend = .01) than it was in low-grade (G1) tumors (3.5 ± 3.1, 1.1 ± 1.1, 2.5 ± 2.5, and 3.6 ± 3.2 alterations per tumor; Ptrend = .79). The mean number of chromosomal alterations also increased with tumor stage and grade (Ptrend<.001) independently of arsenic exposure but was not associated with smoking history. Deletion of part or all of chromosome 17p (Ptrend<.001) showed the strongest association with arsenic exposure. Conclusions: Bladder tumors in patients with higher levels of arsenic exposure showed higher levels of chromosomal instability. Most of the chromosomal alterations associated with arsenic exposure were also associated with tumor stage and grade, raising the possibility that bladder tumors from arsenic-exposed patients may behave more aggressively than tumors from unexposed patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. Nymark, E. Kettunen, M. Aavikko, S. Ruosaari, E. Kuosma, E. Vanhala, K. Salmenkivi, R. Pirinen, A. Karjalainen, S. Knuutila, et al.
Molecular Alterations at 9q33.1 and Polyploidy in Asbestos-Related Lung Cancer
Clin. Cancer Res., January 15, 2009; 15(2): 468 - 475.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
X. Wu, J. Lin, H. B. Grossman, M. Huang, J. Gu, C. J. Etzel, C. I. Amos, C. P. Dinney, and M. R. Spitz
Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals
J. Clin. Oncol., November 1, 2007; 25(31): 4974 - 4981.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. Marshall, C. Ferreccio, Y. Yuan, M. N. Bates, C. Steinmaus, S. Selvin, J. Liaw, and A. H. Smith
Fifty-Year Study of Lung and Bladder Cancer Mortality in Chile Related to Arsenic in Drinking Water
J Natl Cancer Inst, June 20, 2007; 99(12): 920 - 928.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.D. Evans, K. LaDow, B.L. Schumann, R.E. Savage Jr, J. Caruso, A. Vonderheide, P. Succop, and G. Talaska
Effect of arsenic on benzo[a]pyrene DNA adduct levels in mouse skin and lung
Carcinogenesis, April 1, 2004; 25(4): 493 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. N. Bates, O. A. Rey, M. L. Biggs, C. Hopenhayn, L. E. Moore, D. Kalman, C. Steinmaus, and A. H. Smith
Case-Control Study of Bladder Cancer and Exposure to Arsenic in Argentina
Am. J. Epidemiol., February 15, 2004; 159(4): 381 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
Xing Cui, Song Li, A. Shraim, Y. Kobayashi, T. Hayakawa, S. Kanno, M. Yamamoto, and S. Hirano
Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat Liver
Toxicol Pathol, January 1, 2004; 32(1): 64 - 72.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
L. E. Moore, A. H. Smith, C. Eng, S. DeVries, D. Kalman, V. Bhargava, K. Chew, C. Ferreccio, O. A. Rey, C. Hopenhayn, et al.
P53 alterations in bladder tumors from arsenic and tobacco exposed patients
Carcinogenesis, November 1, 2003; 24(11): 1785 - 1791.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.